I notice that FPH, Fisher & Paykel Healthcare, has been going up in this rout. Inter alia, FPH supply breathing equipment to hospitals and have been supplying demand from China.
In about one month from now, every imaging machine in the US, along with the rest of their health care system, will be running absolutely flat out. The increase in the pay per view income should provide an immediate benefit to PME’s bottom line in this FY.
FPH, a manufacturer, with a 5 year sales growth of 13.2%PA, has a trailing PE of 62.4 and forecast PE of 54.3
Whereas, PME, is a purveyor of weightless, infinitely reproducible software, which is created with scarcely any necessity to go near the public and no reliance on workers in factories. PME has a 5-year sales growth of 39.3%PA and now has a trailing PE of 91.7, and a forecast PE of 70.2.
FPH’s share price is rising and PME’s is being clobbered – go figure.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)